Figure 9.
Effects of scutellarin on plasma levels of TNF-α, IL-1β, IL-6, and IFN-γ. Plasma levels of TNF-α and IL-6 were significantly decreased in the scutellarin treated APP/PS1 mice, * p < 0.05 versus APP/PS1 control mice. No significant differences are observed in plasma levels of IL-1β and IFN-γ among the groups, p > 0.05 versus APP/PS1 control mice.